Cardiovascular Endocrinology

Increase in worldwide prevalence of obesity-associated diabetes, dyslipidemia and hypertension makes it imperative that endocrinologists, cardiologists and others have a forum for new treatment and therapeutic developments. Patients with diabetes are at increased risk of developing a number of serious microvascular and macrovascular complications. Across all ages, the relative risk of developing cardiovascular disease (CVD) is ∼2 for patients with diabetes compared with the general population and CVD contributes significantly to the increased, albeit decreasing over time, mortality rate.


    Related Conference of Cardiovascular Endocrinology

    March 25-26, 2024

    5th Annual Conference on Diabetes

    London, UK
    July 11-12, 2024

    7th Annual Meeting on Diabetes and Endocrinology

    Paris, France
    September 09-10, 2024

    4th European Endocrinology and Diabetes Congress

    Paris, France
    November 22-23, 2024

    20th World Congress on Endocrinology & Diabetes

    Amsterdam, Netherlands

    Cardiovascular Endocrinology Conference Speakers

      Recommended Sessions

      Related Journals

      Are you interested in